Friday 6 November 2026 Export AVTR’s income statement to Excel — free account

Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue: +4.59%
EPS: +128.9%
Free cash flow: −9.03%
Total debt: −4.51%

Quarter to September 2026, against a year earlier

Insider buying

15.14 0.51 −3.26%

Follow AVTR

Alert me

Market cap: $10.3B
P/E: 30.3×
Fwd P/E: 34.8×
Dividend yield: —
F-score: 4/9
Altman Z: 1.55
Beneish M: −2.91
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Avantor, Inc. 10-Q filed Oct 28, 2026

Fiscal Q3 2026 · Period ended Sep 30, 2026 · Filed Oct 28, 2026 · accepted 9:03 AM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed Jul 29, 2026: no changes